SCHEMBL8530209

SCHEMBL8530209

Cc1cc2cc(I)c(F)cc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 2/20 0.42
CYP2A6 P11509 1/20 0.42
AXL P30530 1/20 0.40
P2RX7 Q99572 3/20 0.35
NFE2L2 Q16236 1/20 0.34
MAPT P10636 4/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.31
PTGS2 P35354 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
EIF4A3 P38919 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12475503 0.85 KEAP1 (0.47) KEAP1CYP2A6AXLP2RX7NFE2L2
SCHEMBL13062674 0.81 KEAP1 (0.44) KEAP1CYP2A6AXLP2RX7NFE2L2
SCHEMBL2925830 0.78 KEAP1 (0.41) KEAP1CYP2A6AXLP2RX7NFE2L2
SCHEMBL12669319 0.78 ALDH1A1 (0.47) KEAP1CYP2A6AXLP2RX7NFE2L2
SCHEMBL12123168 0.77 CYP2A6 (0.56) KEAP1CYP2A6AXLMAPTKDM4E
SCHEMBL298208 0.75 AXL (0.49) KEAP1CYP2A6AXLMAPTKDM4E
SCHEMBL5989670 0.75 EIF4A3 (0.51) KEAP1CYP2A6AXLP2RX7NFE2L2
SCHEMBL4430051 0.74 CYP2A6 (0.54) KEAP1CYP2A6AXLMAPTKDM4E
SCHEMBL12804231 0.73 KEAP1 (0.42) KEAP1CYP2A6AXLP2RX7NFE2L2
SCHEMBL24103674 0.72 EIF4A3 (0.45) KEAP1CYP2A6AXLP2RX7NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012083164-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-06-21 WO disclosed
EP-2455376-A1 Heterocyclic compounds as inhibitors of hepatitis C virus (HCV) Abbott Laboratories (US) 2012-05-23 EP disclosed
EP-2368890-A1 Hepatitis C virus inhibitors Abbott Laboratories (US) 2011-09-28 EP disclosed
WO-2010144646-A2 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2010-12-16 WO disclosed
WO-2010120935-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2010-10-21 WO disclosed